AVEO Oncology
AVEO
#7389
Rank
A$0.75 B
Marketcap
A$21.60
Share price
0.00%
Change (1 day)
154.37%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -A$40.76 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are A$94.31 Million. In 2021 the company made an earning of -A$76.81 Million a decrease over its 2020 earnings that were of -A$51.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -A$40.76 Million-46.93%
2021 -A$76.81 Million49.9%
2020 -A$51.24 Million-479.04%
2019 A$13.51 M-276.17%
2018 -A$7.68 Million-91.79%
2017 -A$93.49 Million142.38%
2016 -A$38.57 Million78.51%
2015 -A$21.61 Million-71.55%
2014 -A$75.94 Million-50.72%
2013 -A$0.16 Billion-4.88%
2012 -A$0.17 Billion-426.29%
2011 A$49.65 M-159.85%
2010 -A$82.97 Million35.33%
2009 -A$61.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$44.81 B-107,283.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.08 B-31,392.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.33 B-5,689.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.42 B-17,858.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.81 B-33,148.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-A$3.26 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA